UBS Group’s AllianzIM U.S. Equity Buffer10 Nov ETF NVBT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
– Sell
-115
Closed -$4.12K – 10851
2026
Q1
$4.12K Buy
+115
New +$4.23K ﹤0.01% 8987
2025
Q4
– Sell
-2,823
Closed -$102K – 10973
2025
Q3
$102K Sell
2,823
-1,980
-41% -$69.7K ﹤0.01% 7114
2025
Q2
$165K Buy
4,803
+2,448
+104% +$79.3K ﹤0.01% 6848
2025
Q1
$75.1K Buy
+2,355
New +$77.3K ﹤0.01% 7268
2024
Q4
– Sell
-4,817
Closed -$153K – 10253
2024
Q3
$153K Sell
4,817
-3,337
-41% -$105K ﹤0.01% 6061
2024
Q2
$254K Buy
8,154
+5,906
+263% +$181K ﹤0.01% 5505
2024
Q1
$68.4K Buy
2,248
+526
+31% +$15.7K ﹤0.01% 6374
2023
Q4
$50.2K Buy
+1,722
New +$48.3K ﹤0.01% 6535

Other funds holding NVBT

UBS Group's NVBT Position: Q2 2026 in Review

UBS Group sold out of AllianzIM U.S. Equity Buffer10 Nov ETF (NVBT) in Q2 2026, closing a stake of 115 shares — an estimated $4.12K sold.

UBS Group first reported a position in NVBT in Q4 2023 and held it in 8 quarters. The position peaked at $254K in Q2 2024. 26 funds tracked by Wall St. Rank hold NVBT as of Q2 2026.

  • UBS Group reported no remaining AllianzIM U.S. Equity Buffer10 Nov ETF position as of Q2 2026 after selling out during the quarter.
  • UBS Group sold 115 AllianzIM U.S. Equity Buffer10 Nov ETF shares in Q2 2026, an estimated $4.12K.
  • UBS Group first reported a position in AllianzIM U.S. Equity Buffer10 Nov ETF in Q4 2023 and held it in 8 quarters.
  • UBS Group's AllianzIM U.S. Equity Buffer10 Nov ETF position peaked at $254K in Q2 2024.
  • 26 funds tracked by Wall St. Rank held AllianzIM U.S. Equity Buffer10 Nov ETF as of Q2 2026.

Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.